Cardiac Implantable Electronic Device (CIED) Research Study
- Conditions
- TachycardiaArrhythmias, CardiacBradycardia
- Interventions
- Device: cardiac implantable electronic devices (CIEDs)
- Registration Number
- NCT05061862
- Lead Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Brief Summary
The study is designed to collect data on Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details, and/or patient characteristics to support development of future CIED products and procedures.
- Detailed Description
This is a data collection, non-randomized, multi-center study. The study will consist of different cohorts with each cohort being independent from another cohort. Each cohort may have a distinct objective, cohort-specific subject population, procedures, and assessments. The study will follow subjects receiving routine care, who meet all of the inclusion criteria and none of the exclusion criteria.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- Subject is at least 18 years of age.
- Subject is willing and able to provide written informed consent.
- Subject is willing and able to complete the study procedures and visits for the duration of data collection requirements
- Subject is unwilling or unable to comply with study procedures as defined in the protocol.
- Subject with a medical condition that precludes the patient from participation in the opinion of the investigator.
- Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CIED Indicated Subjects cardiac implantable electronic devices (CIEDs) Subjects indicated to receive a cardiac implantable electronic devices (CIEDs)
- Primary Outcome Measures
Name Time Method Product Development 3 years Characterize Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details and/or patient characteristics to support development of future CIED products and procedures.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
UZ Leuven - Campus Gasthuisberg
🇧🇪Leuven, Belgium
The Cardiac & Vascular Institute
🇺🇸Gainesville, Florida, United States
Georgia Arrhythmia Consultants
🇺🇸Macon, Georgia, United States
Oregon Health & Science University Hospital
🇺🇸Portland, Oregon, United States
Lancaster General Hospital
🇺🇸Lancaster, Pennsylvania, United States
Allegheny General Hospital
🇺🇸Pittsburgh, Pennsylvania, United States
University of Virginia Medical Center
🇺🇸Charlottesville, Virginia, United States
Inova Fairfax Hospital
🇺🇸Falls Church, Virginia, United States
Sentara Norfolk General Hospital
🇺🇸Norfolk, Virginia, United States